Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and efficacy of renal sympathetic denervation: a 9-year long-term follow-up of 24-hour ambulatory blood pressure measurements
Alexander Vogt, Jochen Dutzmann, Michael Nußbaum, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 17

Showing 17 citing articles:

Long-Term Blood Pressure Reductions Following Catheter-Based Renal Denervation: A Systematic Review and Meta-Analysis
Gianni Sesa-Ashton, Janis M. Nolde, Ida Muente, et al.
Hypertension (2024) Vol. 81, Iss. 6
Closed Access | Times Cited: 15
Renal denervation for uncontrolled hypertension: a systematic review and meta-analysis examining multiple subgroups
Andrew S.P. Sharp, Alice Sanderson, Neil Hansell, et al.
Journal of Hypertension (2024) Vol. 42, Iss. 7, pp. 1133-1144
Open Access | Times Cited: 12
Cost-effectiveness of catheter-based radiofrequency renal denervation for the treatment of uncontrolled hypertension: an analysis for the UK based on recent clinical evidence
Andrew S.P. Sharp, Khoa N. Cao, Murray Esler, et al.
European Heart Journal - Quality of Care and Clinical Outcomes (2024) Vol. 10, Iss. 8, pp. 698-708
Open Access | Times Cited: 11
Effects of renal denervation on blood pressure in patients with hypertension: a latest systematic review and meta-analysis of randomized sham-controlled trials
Yukako Ogoyama, Makiko Abe, Keisuke Okamura, et al.
Hypertension Research (2024) Vol. 47, Iss. 10, pp. 2745-2759
Closed Access | Times Cited: 9
Long-Term, Patient-Level Analysis of Radiofrequency Renal Denervation in the SYMPLICITY Clinical Trial Program
Felix Mahfoud, Raymond R. Townsend, David E. Kandzari, et al.
JACC Advances (2025) Vol. 4, Iss. 3, pp. 101606-101606
Open Access | Times Cited: 1
Catheter-Based Radiofrequency Renal Denervation in the United States: A Cost-Effectiveness Analysis Based on Contemporary Evidence
David E. Kandzari, Khoa N. Cao, Anne M. Ryschon, et al.
Journal of the Society for Cardiovascular Angiography & Interventions (2024) Vol. 3, Iss. 10, pp. 102234-102234
Open Access | Times Cited: 6
Sympathetic Pathophysiology in Hypertension Origins: The Path to Renal Denervation
Murray Esler, John W. Osborn, Markus P. Schlaich
Hypertension (2024) Vol. 81, Iss. 6, pp. 1194-1205
Closed Access | Times Cited: 5
Effects of renal denervation on the incidence and severity of cardiovascular diseases
Kenichi Katsurada, Kazuomi Kario
Hypertension Research (2024) Vol. 47, Iss. 10, pp. 2700-2710
Closed Access | Times Cited: 3
Cost‐Effectiveness of Radiofrequency Renal Denervation for Uncontrolled Hypertension in Japan
Kazuomi Kario, Khoa N. Cao, Yuji Tanaka, et al.
Journal of Clinical Hypertension (2024) Vol. 26, Iss. 12, pp. 1502-1512
Open Access | Times Cited: 3
The role of renal denervation in cardiology and beyond: An updated comprehensive review and future directives
Aman Goyal, Hritvik Jain, Amogh Verma, et al.
Current Problems in Cardiology (2023) Vol. 49, Iss. 2, pp. 102196-102196
Closed Access | Times Cited: 5
Left ventricular structure and function following renal sympathetic denervation in patients with HFpEF: an echocardiographic 9-year long-term follow-up
Alexander Vogt, Alexander Plehn, Carlo Atti, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Response to ‘Why the lack of enthusiasm for renal denervation?’
Andrew S.P. Sharp, Alice Sanderson, Neil Hansell, et al.
Journal of Hypertension (2024) Vol. 42, Iss. 12, pp. 2215-2217
Closed Access | Times Cited: 1
Cost-effectiveness analysis of radiofrequency renal denervation for uncontrolled hypertension in Canada
Phil McFarlane, Mina Madan, Anne M. Ryschon, et al.
Journal of Medical Economics (2024), pp. 1-34
Open Access | Times Cited: 1
Impact of expected blood pressure reduction on patient preferences for pharmaceutical and renal denervation treatment
Atul Pathak, Michael A. Weber, Christine Poulos, et al.
Journal of Hypertension (2024)
Closed Access
Blood Pressure Control and Clinical Outcomes After Renal Denervation Through Irrigated Catheter Radiofrequency Ablation in Patients with Resistant Hypertension: A Case Series with Up to 10 Years of Follow-Up
Laize Guedes do Carmo, Kelton Dantas Pereira, Mióriel de Aquino Goulart, et al.
High Blood Pressure & Cardiovascular Prevention (2024)
Closed Access
Medication Changes After Renal Denervation: Current Evidence and Patient Perspectives
Zhipeng Zhang, Fei Zhao, Runyu Ye, et al.
Journal of the American Heart Association (2024)
Open Access
Denervação simpática renal como tratamento da hipertensão arterial sistêmica secundária
Ryan Lucas Barbosa Oliveira, Amanda Maria Gonçalves Dos Santos, Emilly Artuso Desbessel, et al.
Brazilian Journal of Health Review (2023) Vol. 6, Iss. 5, pp. 23151-23160
Open Access
Page 1

Scroll to top